Owner and President
With a rich tapestry of over 25 years in Organizational Leadership, especially within the Capital Equipment Sector, Brian has woven a journey of entrepreneurship and visionary leadership at Dynavision Global Holdings, which he founded in 2019. Taking the helm as President, he navigated the acquisition of Dynavision International in October 2019, reigniting the remarkable trajectory of a business that sits at the intersection of technology and cognitive training. Brian has been instrumental in propelling the innovative Dynavision D2™ device into various market channels, impacting athletics, hospitals, and rehab clinics nationwide. This family synergy has kindled a collective passion to foster healing and performance enhancement, ensuring that the limitless opportunities of Dynavision D2™ continue to illuminate numerous pathways in cognitive training and rehabilitation.
Managing Director
With a deep-seated expertise in Human Resources and Financial Management, Mary Ann has adeptly steered the company through the complex maze of the manufacturing industry. Her commitment goes beyond merely upholding the stellar reputation of Dynavision D2™. Mary Ann passionately nurtures relationships with customers and stakeholders, simultaneously broadening the company’s research endeavors and consistently emphasizing its unmatched value in enhancing performance across a myriad of training and rehabilitation environments. Her leadership philosophy, rooted in the cultivation of an innovative and customer-centric team culture, ensures that Dynavision not merely meets, but persistently surpasses, the evolving needs and expectations of its wide-ranging clientele.
Chief Science Officer
As Chief Science Officer of Dynavision International, Jon
Vincent brings a multidisciplinary background spanning neuroscience, biomedical
research, business, and competitive athletics. A former NCAA Division I
football player at the University of Cincinnati, Jon combines firsthand
experience in athletic performance with advanced scientific training, holding a
PhD in Neuroscience and an MBA while pursuing his medical degree. His doctoral
research focused on neuroinflammation and synaptic dysfunction following
traumatic brain injury, informing his broader interests in neurorehabilitation,
cognitive performance, and translational medicine.
At Dynavision, Jon provides scientific leadership at the
intersection of research, technology development, and clinical application,
bridging emerging neuroscience with practical solutions for rehabilitation and
human performance. His work emphasizes advancing the Dynavision D2™ through
scientific rigor, evidence-based innovation, and collaboration with clinicians,
researchers, and performance professionals. Drawing on his scientific, athletic, and business experience, Jon is committed to expanding Dynavision technology’s clinical and performance applications.
